Johnson & Johnson
NYSE:JNJDrug Manufacturers - General
Healthcare
$272.70 -1.96%
-$4.59 today
- Market cap
- $656.47B
- Beta
- 0.26
- P/E (TTM)
- 26.7
- EPS (TTM)
- $8.60
- Dividend yield
- 2.28%
52W Low $149.04High $251.71
Volume 7.93M
Average 7.71M
News
For Johnson & Johnson, read summarized stories built from several publishers and recent headlines with links to the original coverage.
Stories
All market newsNo stories for JNJ yet. A story appears once at least three publishers cover the same event.
More headlines
Recent coverage that has not been summarized. Links open the publisher's site.
- Invest $25,000 in These 4 Dividend Stocks to Start Building Retirement Income
24/7 Wall Street
- Here's How Much Passive Income $50,000 Generates in These 4 Dividend Aristocrats
24/7 Wall Street
- 2 of the Best Dividend Stocks to Buy With $5,000 in November
Fool - Investing News
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ
GlobeNewsWire
- Louisiana Appeals Court Upholds Millions in Damages in Mesothelioma Case Against Johnson & Johnson
Business Wire
- J&J to Acquire Ollin Biosciences: A Look at Its Recent Buyouts
Zacks Investment Research
- J&J to Boost Ophthalmology Pipeline With $2.2B Ollin Acquisition
Zacks Investment Research
- Wall Street Analysts Think Johnson & Johnson (JNJ) Is a Good Investment: Is It?
Zacks Investment Research
- Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock
Zacks Investment Research
- 3 Bulletproof Passive Income Dividend Kings to Buy and Hold Forever
24/7 Wall Street
- Johnson & Johnson vs. Novo Nordisk: Steady Uptrend vs.
The Motley Fool
- 40,053 Johnson & Johnson $JNJ Shares Bought by Banco Santander S.A.
Defense World
- Johnson & Johnson (NYSE:JNJ) Stock Falls 1.1% After Insider Selling
Defense World
Continue the stock analysis
Jump to another research area for this company.